Bio-Rad Laboratories, Inc. announced Operating income margin guidance remains at about 19% as they manage operating expense plan for the remainder of this year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
293.8 USD | -0.64% | +4.20% | -8.99% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.99% | 8.31B | |
-5.43% | 181B | |
+4.30% | 114B | |
-3.09% | 68.29B | |
+5.86% | 52.24B | |
+8.15% | 44.3B | |
+6.67% | 42.73B | |
+25.54% | 32.52B | |
+20.03% | 26.02B | |
+1.00% | 25.91B |
- Stock Market
- Equities
- BIO Stock
- News Bio-Rad Laboratories, Inc.
- Bio-Rad Laboratories, Inc. Provides Earnings Guidance for the Year 2022